Focus on urinary bladder cancer markers: a review.
D021322:Antifreeze Proteins, Type I / Q000652:urine; D000951:Antigens, Neoplasm / Q000652:urine; D014408:Biomarkers, Tumor / Q000652:urine*; D015853:Cysteine Proteinase Inhibitors / Q000652:urine; D006417:Hematuria / Q000652:urine; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins; D053539:Keratin-19 / Q000652:urine; D053554:Keratin-20 / Q000652:urine; D007633:Keratins / Q000652:urine; D008869:Microtubule-Associated Proteins / Q000652:urine; D009687:Nuclear Proteins / Q000652:urine; D011237:Predictive Value of Tests; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D051498:Receptor, Fibroblast Growth Factor, Type 3 / Q000652:urine; D055293:Receptors, Urokinase Plasminogen Activator / Q000378:metabolism; D012680:Sensitivity and Specificity; D000077022:Survivin; D019396:Tissue Polypeptide Antigen / Q000652:urine; D016159:Tumor Suppressor Protein p53 / Q000096:biosynthesis; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000652:urine*
D021322:Antifreeze Proteins, Type I; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D015853:Cysteine Proteinase Inhibitors; D051034:Inhibitor of Apoptosis Proteins; D053539:Keratin-19; D053554:Keratin-20; D007633:Keratins; D008869:Microtubule-Associated Proteins; D009687:Nuclear Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3; D055293:Receptors, Urokinase Plasminogen Activator; D000077022:Survivin; D019396:Tissue Polypeptide Antigen; D016159:Tumor Suppressor Protein p53; C107489:BIRC5 protein, human; C102012:antigen CYFRA21.1; C100379:nuclear matrix protein 22; C508053:ERBB2 protein, human; C496365:FGFR3 protein, human